Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin"s lymphoma.

  • 2.82 MB
  • 110 Downloads
  • English
by
National Institute for Clinical Excellence , London
SeriesTechnology appraisal guidance -- no.35
ID Numbers
Open LibraryOL18589252M

Download Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin"s lymphoma. FB2